Class: Diuretic (Non-Metabolized Osmotic Diuretic) Class: Diuretic (Carbonic Anhydrase Inhibitor)
Mech.: Filtered into tubule space → ↑↑ tubular fluid osmolality → ↓ fluid Mech.: Inhib. of CA → ↓ reabsorption of NaHCO3 in prox. tubule. K+ is
reabsorption → ↑ excretion of water and some Na+ . exchanged for Na+ in distal tubule. Net = ↑ in urinary HCO3-, K+ , and
water excretion.
Absorption: IV only (oral → osmotic diarrhea). Takes effect in 10 min.
Absorption: Oral. Takes effect in 30 min.
Dist.:
Dist.:
Metab.:
Metab.:
Excretion, t_: 1.2 hr.
Excretion, t_: 13 hr.
Toxicity/S.E.s: ↑ plasma osmolality. If GFR is reduced (e.g., renal failure or
Toxicity/S.E.s: Metabolic acidosis, hypokalemia. C/i—cirrhosis.
CHF), mannitol stays in ECF → water movement from cells to ECF
Utility: Treat glaucoma and ↑ CNS pressure. Alkalinize urine. Prevent altitude
→ potential production/exacerbation of heart failure and
sickness. Diuresis.
hyponatremia. C/i—CHF, renal failure.
Special Features: Relatively weak diuretic. Generally prescribed for non-
Utility: Prophylaxis against renal dysfunction (e.g., in major surgical procedures). diuretic purposes. Effectiveness reduced w/continued
Special Features: therapy because plasma [HCO3-] falls.
1 www.brain101.info
Name: Ethacrynic Acid (Edecrin) Name: Hydrochlorothiazide (Hydrodiuril)
Class: Diuretic (Loop Diuretic) Class: Diuretic (Thiazide)
Mech.: Blocks the Na+ /K+ /Cl- co-transporter in the apical membrane of the thick Mech.: Inhib. Na+ & Cl- transport in the cortical thick ascending limb and the early
ascending limb of Henle’s loop → ↑ excretion of urinary water, Na+ , K+ , distal tubule → ↑ NaCl and water excretion, & ↓ excretion of Ca2+ and uric
Ca2+, & Mg2+. Also causes venous and renal vasodilation. acid.
Absorption: Oral, IV. Takes effect in 20 min. Absorption: Oral → good absorption. Takes effect in 1 hr.
Dist.: Metab.: Dist.: Metab.: Excretion, t_: Short duration of action.
Excretion, t_: 1-1.5 hr. Toxicity/S.E.s: Hypokalemia, hyponatremia, hyperuricemia, weakness,
Toxicity/S.E.s: Hypokalemia (esp. dangerous if pt. is on digitalis), Ca2+ & Mg2+ hypercalcemia, metabolic alkalosis, postural hypotension, hypercholesterolemia,
depletion, metabolic alkalosis, volume contraction, mild hyperglycemia, hypertriglyceridemia, hyperglycemia (in patients w/DM), and rare hypersensitivity
ototoxicity. C/i—pts. susceptible to volume contraction from excessive rxns. C/i—pts susceptible to problems with hypokalemia (cirrhosis, pts on
diuresis (e.g., elderly), and pts. susceptible to problems w/hypokalemia digitalis), hyperuricemia (gout), or hypercalcemia. Adverse rxns w/digitalis,
(e.g., cirrhosis, pts. taking digitalis). lithium. Altered doses of anti-diabetic agents required. Long-term NSAID use
Utility: Diuresis for hypertension when a short-acting diuretic is indicated. Very may decrease anti-HTN effects.
useful in conditions refractory to less potent diuretics, including CHF, renal Utility: Treat hypertension, CHF, nephrotic synd., other Na+ -retaining states.
insufficiency, and nephrotic synd. Also used to treat hypercalcemia. Reduce Ca2+ excretion (e.g., prevention of kidney stones).
Special Features: More ototoxic than other loop diuretics. Most potent diuretics Special Features: Most commonly prescribed class of diuretics. Most frequently
available. Can cause excretion of up to 20% of filtered Na+ . used anti-HTN class of agents. Milder diuretic action than loop diuretics.
Rel. ineffective in renal insuff.
2 www.brain101.info
Name: Metolazone (Mykrox) Name: Triamterene (Dyrenium)
Class: Diuretic (Thiazide-Like) Class: Diuretic (Potassium Sparing Diuretic)
Mech.: Inhib. Na+ & Cl- transport in the cortical thick ascending limb and the early Mech.: Inhib. Na+ channel in the apical membrane of the late distal tubule and
distal tubule → ↑ NaCl and water excretion, & ↓ excretion of Ca2+ and uric collecting duct → block of electrochemical gradient that drives K+ & H+
acid. secretion → diuresis & ↓ excretion of K+ & H+ . Weak anti-HTN activity.
Absorption: Oral → good absorption. Takes effect in 1 hr. Absorption: Oral
Dist.:
Dist.: Metab.: Excretion, t_:
Metab.:
Toxicity/S.E.s: Hypokalemia, hyponatremia, hyperuricemia, hypercalcemia,
metabolic alkalosis, postural hypotension, hyperglycemia (in Excretion, t_: 1° = kidney. 3 hr.
patients w/DM), and rare hypersensitivity rxns. C/i—pts Toxicity/S.E.s: Hyperkalemia (most severe), n/v (most common), metabolic
susceptible to problems w/hypokalemia (cirrhosis, pts on digitalis), acidosis. Hyponatremia may occur in old folks. Absolutely
hyperuricemia (gout), or hypercalcemia. contraindicated with hyperkalemia. Adverse rxns w/lithium, ACE
Utility: The only distal nephron diuretic efficacious in patients w/severe renal inhibitors. Rare renal failure w/NSAIDs.
insufficiency. Treat hypertension, CHF, nephrotic synd., other Na+ - Utility: Usu. given w/another diuretic (often thiazide or loop). Combination usu.
retaining states. Reduce Ca2+ excretion (e.g., prevention of kidney → normal K+ excretion. Used to prevent or correct hypokalemia, and to
stones). avoid K+ depletion in pts. on digitalis.
Special Features: Strongest inhib. of Na+ & water reabsorption of the thiazide Special Features: Rel. weak diuretic.
and thiazide-like diuretics. Often given in comb. w/a loop diuretic. Milder
diuretic action than loop diuretics.
3 www.brain101.info